MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway
Authors:
- 26 November 2015
- journal article
- research article
- Published by Spandidos Publications in Oncology Reports
- Vol. 35 (2) , 887-895
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 35 references indexed in Scilit:
- The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma ProgressionJNCI: Journal of the National Cancer Institute, 2013
- Upregulation of miR‐153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancerThe Prostate, 2012
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- miR‐340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c‐MetCancer, 2011
- Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cellsCell Death & Disease, 2010
- Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor modelNature Biotechnology, 2010
- Discovery and Optimization of Chromenotriazolopyrimidines as Potent Inhibitors of the Mouse Double Minute 2−Tumor Protein 53 Protein−Protein InteractionJournal of Medicinal Chemistry, 2009
- The impact of microRNAs on protein outputNature, 2008
- In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2Science, 2004
- Abnormal Expression of MDM2 in Prostate CarcinomaLaboratory Investigation, 2001